Skip to content

Impact Of Short Message Alerting On Medical Management Of Patients With Renal failure

Impact Of Short Message Alerting On Medical Management Of Patients With Renal failure

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013101414727N4
Enrollment
137
Registered
2014-01-01
Start date
2012-08-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Renal Failure- Renal Impairment. Condition 2: Renal Failure- Renal Impairment. Condition 3: Renal Failure- Renal Impairment. acute renal impairment chronic kidney disease unspecified kidney failure

Interventions

Intervention group: Sending short message alert to physician if patient's GFR is less than 50 ml/minute
Control group: Not sending short message alert to physician if patient's GFR is less than 50 ml/minute
Intervention 1: Intervention group: Sending short message alert to physician if patient's GFR is less than 50 ml/minute. Intervention 2: Control group: Not sending short message alert to physician if
Behavior

Sponsors

Masih Daneshvari National Research Institute of Tuberculosis and Lung Disease
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1) Receiving at least one of the selected drugs in the study with the most inappropriate dosing rate 2) Patients under observation of one of the physicians who enrolled in the study 3) Patients with GFR under 50 ml/minute Exclusion criteria: 1) Not receiving at least one of the selected drugs 2) Not being observed by one of the enrolled physicians 3) Patients with GFR higher than 50 ml/minute 4) Patients whose weight and height were not accessible 5) Patients who undergo dialysis

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Discontinuation of medication. Timepoint: 0-6 hours, 6-24 hours and 24-48 hours intervals. Method of measurement: Medical records and patient's file.;Dose Adjustment. Timepoint: 0-6 hours, 6-24 hours and 24-48 hours interval. Method of measurement: Medical records and patient's file.;No action. Timepoint: 0-6 hours, 6-24 hours and 24-48 hours interval. Method of measurement: Medical records and patient's file.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Fanak Fahimi

Shahid beheshti university of medical sciences, Faculty Of Pharmacy

fanakfahimi@yahoo.com; fahimi@sbmu.ac.ir; aida.forough67@gmail.com+98 21 2610 9503

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026